Risk prediction models: II. External validation, model updating, and impact assessment

Karel G.M. Moons, Andre Pascal Kengne, Diederick E. Grobbee, Patrick Royston, Yvonne Vergouwe, Douglas G. Altman, Mark Woodward

Research output: Contribution to journalReview articlepeer-review

Abstract

Clinical prediction models are increasingly used to complement clinical reasoning and decision-making in modern medicine, in general, and in the cardiovascular domain, in particular. To these ends, developed models first and foremost need to provide accurate and (internally and externally) validated estimates of probabilities of specific health conditions or outcomes in the targeted individuals. Subsequently, the adoption of such models by professionals must guide their decisionmaking, and improve patient outcomes and the costeffectiveness of care. In the first paper of this series of two companion papers, issues relating to prediction model development, their internal validation, and estimating the added value of a new (bio)marker to existing predictors were discussed. In this second paper, an overview is provided of the consecutive steps for the assessment of the model's predictive performance in new individuals (external validation studies), how to adjust or update existing models to local circumstances or with new predictors, and how to investigate the impact of the uptake of prediction models on clinical decision-making and patient outcomes (impact studies). Each step is illustrated with empirical examples from the cardiovascular field.

Original languageEnglish (US)
Pages (from-to)691-698
Number of pages8
JournalHeart
Volume98
Issue number9
DOIs
StatePublished - May 2012

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Risk prediction models: II. External validation, model updating, and impact assessment'. Together they form a unique fingerprint.

Cite this